Michael Potter, MD
Orthopaedic Surgery · Rolla, MONPI 1770748154
Payments from drug & device makers
Across 91 payments — averaging $92.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elite Orthopedics, LLC$2K
- Stryker$2K
- Smith+Nephew$2K
- Arthrex$1K
- AstraZeneca$119
- Ferring Pharmaceuticals Inc.$98
- plus $579 from 13 others
What the payments were for
- Travel & lodging$5,71568%
- Food & beverage$2,68832%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elite Orthopedics, LLC | 8 | $2,354 |
| Stryker | 17 | $2,174 |
| Smith+Nephew | 17 | $2,070 |
| Arthrex | 21 | $1,009 |
| AstraZeneca | 1 | $119 |
| Ferring Pharmaceuticals Inc. | 7 | $98 |
| Heron Therapeutics, Inc. | 1 | $89 |
| Endo Pharmaceuticals Inc. | 4 | $89 |
| Myoscience Inc. | 1 | $84 |
| Endo USA, Inc. | 3 | $74 |
| Avanos Medical | 1 | $71 |
| Pacira Therapeutics, Inc. | 3 | $53 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Apria Healthcare LLC | 1 | $21 |
| Zimmer Biomet | 1 | $19 |
| Bioventus LLC | 1 | $18 |
| Pfizer | 1 | $14 |
| EBI, LLC | 1 | $14 |
| Sonex Health, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,403 in reported general payments places this provider in the 60th percentile of 455 orthopaedic surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rifampin | 42 | $3,780 |
| Celecoxib | 248 | $3,376 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 331 | $2,765 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 360 | $2,542 |
| Vancomycin Hcl | 13 | $2,349 |
| Gabapentin | 229 | $1,991 |
| Naloxone Hcl | 25 | $1,400 |
| Doxycycline Monohydrate | 27 | $1,351 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 41 | $369 |
| Methylprednisolone | 42 | $365 |
| Ondansetron OdtOndansetron | 13 | $144 |
| Cyclobenzaprine Hcl | 19 | $107 |
| Meloxicam | 44 | $99 |
| Tramadol Hcl | 24 | $77 |
| Diazepam | 12 | $19 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Rolla
- Matthew SmithColumbia$4M
- Jay KeenerSaint Louis$2.2M
- John WatsonSaint Louis$1.7M
- Alexandra StrongN Kansas City$1.1M
- Thomas McCormackKansas City$852K
- Michael SnyderJefferson City$676K
- Peter ChalmersSaint Louis$674K
- Paul FrewinSullivan$630K
- Katherine BurnsBridgeton$491K
- Jeremy StattonLees Summit$457K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.